Bio Details

As a venture partner at SR One, Mr. Chai guides portfolio companies on their engagement with investors and overall financing strategy and execution. Throughout his over 20 years of executive management and investment banking experience, Mr. Chai has taken companies public from both the company and the banking side. Prior to joining SR One, Mr. Chai served as Chief Financial Officer of Principia Biopharma, where he led the company from an early-stage private venture-backed company to its acquisition by Sanofi for $3.7 billion. He was previously CFO at MAP Pharmaceuticals (acquired by Allergan) and Vice President, Treasury and Investor Relations at CV Therapeutics (acquired by Gilead). He has built and evolved his teams from private to public company finance organizations. Mr. Chai received his BS in Operations Research and Industrial Engineering from Cornell University.